Olaratumab (Anti-PDGFRA / CD140a)
Olaratumab (IMC-3G3; LY3012207) is a fully human IgG1 monoclonal antibody directed against the platelet-derived growth factor receptor alpha (PDGFR alpha) with potential antineoplastic activity. MW: 145.5 kD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2379 |
Sku # | A2379-1mg |
Pricing | 1mg, $470.00 |